Your browser doesn't support javascript.
loading
Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
Zeng, Chao; Rosenberg, Lynn; Li, Xiaoxiao; Djousse, Luc; Wei, Jie; Lei, Guanghua; Zhang, Yuqing.
Afiliación
  • Zeng C; Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
  • Rosenberg L; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Li X; The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Djousse L; Slone Epidemiology Center at Boston University, Boston, MA, USA.
  • Wei J; Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, China.
  • Lei G; Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Zhang Y; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Eur Heart J ; 43(18): 1743-1755, 2022 05 07.
Article en En | MEDLINE | ID: mdl-35201347
ABSTRACT

AIMS:

Previous studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to compare the risks of incident CVD and all-cause mortality among initiators of sodium-containing acetaminophen with the risk of initiators of non-sodium-containing formulations of the same drug according to the history of hypertension. METHODS AND

RESULTS:

Using The Health Improvement Network, we conducted two cohort studies among individuals with and without hypertension. We examined the relation of sodium-containing acetaminophen to the risk of each outcome during 1-year follow-up using marginal structural models with an inverse probability weighting to adjust for time-varying confounders. The outcomes were incident CVD (myocardial infarction, stroke, and heart failure) and all-cause mortality. Among individuals with hypertension (mean age 73.4 years), 122 CVDs occurred among 4532 initiators of sodium-containing acetaminophen (1-year risk 5.6%) and 3051 among 146 866 non-sodium-containing acetaminophen initiators (1-year risk 4.6%). The average weighted hazard ratio (HR) was 1.59 [95% confidence interval (CI) 1.32-1.92]. Among individuals without hypertension (mean age 71.0 years), 105 CVDs occurred among 5351 initiators of sodium-containing acetaminophen (1-year risk 4.4%) and 2079 among 141 948 non-sodium-containing acetaminophen initiators (1-year risk 3.7%), with an average weighted HR of 1.45 (95% CI 1.18-1.79). Results of specific CVD outcomes and all-cause mortality were similar.

CONCLUSION:

The initiation of sodium-containing acetaminophen was associated with increased risks of CVD and all-cause mortality among individuals with or without hypertension. Our findings suggest that individuals should avoid unnecessary excessive sodium intake through sodium-containing acetaminophen use.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sodio en la Dieta / Enfermedades Cardiovasculares / Hipertensión / Infarto del Miocardio Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Eur Heart J Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sodio en la Dieta / Enfermedades Cardiovasculares / Hipertensión / Infarto del Miocardio Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Eur Heart J Año: 2022 Tipo del documento: Article País de afiliación: China